#ACCAsia: In adults with #CVD in South Korea, the rates of awareness & treatment of key CV risk factors were higher in women than in men, but they had lower rates of risk factor control, particularly for hypertension & hypercholesterolemia.
Read more: https://bit.ly/48as10S #CardioSky #MedSky
In honor of #NationalMinorityHealthMonth, we’re championing inclusive clinical research. Representation in studies helps ensure treatments work across all communities and leads to better, safer care for everyone.
Learn more from #CardioSmart 👉 https://bit.ly/4sz0YUl #ACCHealthEquity #NMHM26
Application Open❗
Apply for the ACC’s Leadership Accelerator Class of 2027 today and join a growing program designed to help #ACCEarlyCareer build core leadership skills and competencies.
Learn more and apply by May 19 👉 https://bit.ly/4l9z2TM #ACCLeadership
"We cannot transform cardiovascular care in siloes. It will take all of us, working together, ..." writes #ACCPresident Roxana Mehran, MD, FACC, in a recent #ACCLeadership Update.
Read more for reflections ➕ highlights from the March BOT Meeting at #ACC26 ➡️ https://bit.ly/4teguGe #ACCBOT
The joint EAPC/ESC and ACC Clinical Consensus Statement provides an in-depth update on the current state of knowledge on abnormal cardiovascular findings in Masters athletes.
Read the journal scan for more 👉 https://bit.ly/4vnexZx #SportsCardio #JACC #CardioSky
🆕 #JACC Spotlight Issue highlights key guideline recommendations for acute #PulmonaryEmbolism through a patient-centered journey – from risk factors to long-term management, while also identifying areas for future clarification and updates.
Read more: https://bit.ly/4cAZoME #CardioSky
Outpatient management of isolated left-to-right shunt lesions in pediatric patients with #CHD is the focus of a 🆕 2026 ACC Concise Clinical Guidance report.
Learn more: https://bit.ly/4sTenY2 #CardioSky #MedSky
📺 Panel Discussion from #ACC26: Dive into the 🆕 Dyslipidemia Guideline and VESALIUS-CV Late-Breaking Clinical Trial with Drs. Fred M. Kusumoto, R. Scott Wright and Eugene Yang.
Watch now on #ACCAnywhere TV! ➡️ https://bit.ly/4c2CRXU
#ACC26 findings aren't just resonating within the cardiology community – they're reaching patients and the wider public too.
Here's a look at some of the standout studies making headlines in major consumer news outlets ➡️ https://bit.ly/4seoOEz #CardiologyMag
The ACC joins with the @worldheart.org to bring together thousands of cardiovascular professionals from across the globe. 🌏
📆 Mark your calendar for #ACC27 Together With WCC, taking place April 10 – 12, 2027 in Houston, TX! We hope to see you there! 🔗 https://bit.ly/4m4y9xj
📣 #ACC26 Attendees: Catch up on sessions you missed with access to 200+ sessions from ACC.26 on demand. Your ACC.26 registration includes a three-month FREE trial to #ACCAnywhere.
Activate your ACC Anywhere subscription and continue your learning ➡️ https://bit.ly/3NSOkkM
In a new edition of ACC's Cardiology Hour, Dr. Valentin Fuster & a panel of experts break down the top trials released during #ACC26, such as STEMI-DTU, ORBITA-CTO, & more!
📽️: youtu.be/xvLFmv2-Et0?...
#JACC #CardioSky @accintouch.bsky.social
👏 Congratulations to ACC Vice President Hani K. Najm, MD, MSc, FACC, and all our 🆕 esteemed ACC leaders!
🔗 More about the College's new officers and trustees who took office following Convocation at #ACC26: https://bit.ly/3NDAOS1
#ACCLeadership #CardioSky
Please join us in congratulating new #ACCPresident Roxana Mehran, MD, FACC!
Walking the #ACC26 stage, she shared, “Transforming cardiovascular care for all cannot happen in silos. It requires collaboration.”
💬 https://bit.ly/4m2crKq #ACCLeadership
#ACC26 we see you and your blue!
💙 🩵 💙
From the pickleball court 🏓 to the stages 🎤 and lounges 🛋️, so many of you are showing your ACC pride on the final day of the ACC Annual Scientific Session in New Orleans!
FUND-HF pilot trial at #ACC26: Providing financial support early after hospital discharge to economically vulnerable patients with #heartfailure with reduced ejection fraction is feasible and significantly improved adherence to prescribed medications. 🔗 https://bit.ly/47rgf1O
#ACC26 DKCRUSH VIII: When using the two-stent DK crush technique for #PCI to treat complex coronary artery bifurcation lesions, IVUS-guided PCI was associated w/ a greater reduction in target vessel failure compared to angiography-guided PCI.
More: 🔗 https://bit.ly/47w3WRR #CardioSky #JACC
A noninvasive device used to monitor early fluid accumulation in the lungs of patients with #HFpEF substantially reduced HF hospitalizations and mortality.
Check out the results from the IMPEDANCE-HFPEF trial presented during #ACC26 ➡️ https://bit.ly/47refXm #CardioSky
#ACC26 CORALreef AddOn: The novel PCSK9 oral inhibitor enlicitide effectively lowered LDL-C in adults already being treated with statins, demonstrating a potential role as an add-on option for patients not meeting LDL-C goals.
Learn more: https://bit.ly/4uW7VRL #JACC #CardioSky
A new system that uses #AI to assess CV risk based on retinal images demonstrated a strong correlation with standard cardiovascular risk assessment, according to research presented during an Investigative Horizons session at #ACC26.
Find out more: https://bit.ly/4bU3Swl #CardioSky
Results of IVUS-CHIP and OPTIMAL: When compared with angiography-guided #PCI, IVUS-guided PCI was found to be not superior in patients with 👇
❇️ Complex coronary arteries ➡️ IVUS-CHIP
❇️ Unprotected LM-CAD ➡️ OPTIMAL
More on these #ACC26 LBCT trials: https://bit.ly/3Q7OZiK #CardioSky
#ACC26 SirPAD: For patients with symptomatic infrainguinal artery disease, angioplasty with a sirolimus-coated balloon, compared with an uncoated balloon, reduced major adverse limb events at one year.
Read the full results: https://bit.ly/47Rqj4r #CardioSky
Essence-CTA: Does Olezarsen Reduce Noncalcified Coronary Plaque Volume?
Check out the results of the 🆕 #ACC26 late-breaking clinical trial: https://bit.ly/4tc0UKH #cvLipids #CardioSky
Dig-RHD: Digoxin lowered the risk of death or new-onset or worsening #heartfailure compared with placebo in patients with rheumatic heart disease (RHD). #ACC26
See the full results ➡️ https://bit.ly/4lYK9Al #CardioSky
SMART-DECISION: Discontinuing beta-blocker therapy was found to be noninferior to continuing the therapy among stable, low-risk patients who took it for at least one year following a #cvMI.
Get the latest insights from the #ACC26 LBCT: https://bit.ly/4bPRayM #CardioSky
#ACC26 THRIVE: A culturally tailored food-is-medicine intervention significantly reduced SBP in Black and Hispanic adults with hypertension, compared with those who received an equivalent amount of fresh produce without the additional supports.
Read more: https://bit.ly/4dQA8TF #CardioSky
🎉 Welcome to the final day of #ACC26!
What’s Brewing today? ☕
✅ LBCTs
✅ Personalized Skills Zone
✅ Guideline Goldmine Gameshow
✅ Convocation & Closing Ceremony
➕ More!
Three days of learning. One final day to go all in. Don't miss a beat! 🫀
TRI-FR at #ACC26: T-TEER in addition to standard-of-care medical therapy reduced the risk of death, #cvMI, stroke and hospitalization for #heartfailure compared with standard-of-care alone in patients with severe symptomatic #vhdTR.
Learn more: https://bit.ly/3PCWUVm #CardioSky
PROTECT H2H: Emboliner vs. Sentinel Embolic Protection Devices in #TAVR
Explore the findings from the trial unveiled during a Late-Breaking Clinical Trial session at #ACC26: https://bit.ly/4sFQK5r #CardioSky
🔓 We’re working to unlock a $25,000 matching gift during #ACC26. Every donation gets us closer. Help us:
✔️ Empower future leaders
✔️ Advance science
✔️ Fund Travel Grants for Emerging CV Professionals
Give today. Double your impact.
https://bit.ly/4sZvLKl #ACCGivesBack
